clinical trial · NCT06429137
A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
HealthyBI 3731579Placebo
brief summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3731579 in healthy male subjects.
started
Jul 8, 2024
primary completion
May 19, 2025
completion
May 27, 2025
last updated
Aug 10, 2026
official title
A Partially Randomised, Single-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, and Pharmacokinetics of Single Rising Doses of BI 3731579 Administered as Tablet to Healthy Male Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol